360 related articles for article (PubMed ID: 30831131)
1. Inhibition of RhoA/ROCK signaling pathway ameliorates hypoxic pulmonary hypertension via HIF-1α-dependent functional TRPC channels.
Wang XY; Mo D; Tian W; Liu XX; Zhou YG; Sun Y; Feng YD; Xiao X; Hao XW; Zhang HN; Li C; Cao W; Li XQ
Toxicol Appl Pharmacol; 2019 Apr; 369():60-72. PubMed ID: 30831131
[TBL] [Abstract][Full Text] [Related]
2. Rescue treatment with a Rho-kinase inhibitor normalizes right ventricular function and reverses remodeling in juvenile rats with chronic pulmonary hypertension.
Xu EZ; Kantores C; Ivanovska J; Engelberts D; Kavanagh BP; McNamara PJ; Jankov RP
Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1854-64. PubMed ID: 20889845
[TBL] [Abstract][Full Text] [Related]
3. Fasudil-induced hypoxia-inducible factor-1alpha degradation disrupts a hypoxia-driven vascular endothelial growth factor autocrine mechanism in endothelial cells.
Takata K; Morishige K; Takahashi T; Hashimoto K; Tsutsumi S; Yin L; Ohta T; Kawagoe J; Takahashi K; Kurachi H
Mol Cancer Ther; 2008 Jun; 7(6):1551-61. PubMed ID: 18566226
[TBL] [Abstract][Full Text] [Related]
4. Effects of rho-kinase inhibition on pulmonary hypertension, lung growth, and structure in neonatal rats chronically exposed to hypoxia.
Ziino AJ; Ivanovska J; Belcastro R; Kantores C; Xu EZ; Lau M; McNamara PJ; Tanswell AK; Jankov RP
Pediatr Res; 2010 Feb; 67(2):177-82. PubMed ID: 19858775
[TBL] [Abstract][Full Text] [Related]
5. The xanthine derivative KMUP-1 inhibits models of pulmonary artery hypertension via increased NO and cGMP-dependent inhibition of RhoA/Rho kinase.
Chung HH; Dai ZK; Wu BN; Yeh JL; Chai CY; Chu KS; Liu CP; Chen IJ
Br J Pharmacol; 2010 Jun; 160(4):971-86. PubMed ID: 20590592
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia inducible factor 1 mediates hypoxia-induced TRPC expression and elevated intracellular Ca2+ in pulmonary arterial smooth muscle cells.
Wang J; Weigand L; Lu W; Sylvester JT; Semenza GL; Shimoda LA
Circ Res; 2006 Jun; 98(12):1528-37. PubMed ID: 16709899
[TBL] [Abstract][Full Text] [Related]
7. Chronic hypoxia-induced upregulation of store-operated and receptor-operated Ca2+ channels in pulmonary arterial smooth muscle cells: a novel mechanism of hypoxic pulmonary hypertension.
Lin MJ; Leung GP; Zhang WM; Yang XR; Yip KP; Tse CM; Sham JS
Circ Res; 2004 Sep; 95(5):496-505. PubMed ID: 15256480
[TBL] [Abstract][Full Text] [Related]
8. The mechanism by which RhoA regulates vascular reactivity after hemorrhagic shock in rats.
Li T; Fang Y; Yang G; Zhu Y; Xu J; Liu L
Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H292-9. PubMed ID: 20472763
[TBL] [Abstract][Full Text] [Related]
9. Serotonin and chronic hypoxic pulmonary hypertension activate a NADPH oxidase 4 and TRPM2 dependent pathway for pulmonary arterial smooth muscle cell proliferation and migration.
Song JL; Zheng SY; He RL; Gui LX; Lin MJ; Sham JSK
Vascul Pharmacol; 2021 Jun; 138():106860. PubMed ID: 33794383
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells.
Xie Z; Su W; Guo Z; Pang H; Post SR; Gong MC
Cardiovasc Res; 2006 Feb; 69(2):491-501. PubMed ID: 16336954
[TBL] [Abstract][Full Text] [Related]
11. HDAC5 inhibition reduces angiotensin II-induced vascular contraction, hypertrophy, and oxidative stress in a mouse model.
Bai L; Kee HJ; Choi SY; Seok YM; Kim GR; Kee SJ; Kook H; Jeong MH
Biomed Pharmacother; 2021 Feb; 134():111162. PubMed ID: 33360932
[TBL] [Abstract][Full Text] [Related]
12. Sildenafil inhibits chronically hypoxic upregulation of canonical transient receptor potential expression in rat pulmonary arterial smooth muscle.
Lu W; Ran P; Zhang D; Peng G; Li B; Zhong N; Wang J
Am J Physiol Cell Physiol; 2010 Jan; 298(1):C114-23. PubMed ID: 19889962
[TBL] [Abstract][Full Text] [Related]
13. Reactive oxygen species mediate RhoA/Rho kinase-induced Ca2+ sensitization in pulmonary vascular smooth muscle following chronic hypoxia.
Jernigan NL; Walker BR; Resta TC
Am J Physiol Lung Cell Mol Physiol; 2008 Sep; 295(3):L515-29. PubMed ID: 18621909
[TBL] [Abstract][Full Text] [Related]
14. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway.
Chen XY; Dun JN; Miao QF; Zhang YJ
Pharmacology; 2009; 83(2):67-79. PubMed ID: 19052484
[TBL] [Abstract][Full Text] [Related]
15. Chronic hypoxia induces Rho kinase-dependent myogenic tone in small pulmonary arteries.
Broughton BR; Walker BR; Resta TC
Am J Physiol Lung Cell Mol Physiol; 2008 Apr; 294(4):L797-806. PubMed ID: 18263668
[TBL] [Abstract][Full Text] [Related]
16. Involvement of RhoA/Rho kinase signaling in pulmonary hypertension of the fawn-hooded rat.
Nagaoka T; Gebb SA; Karoor V; Homma N; Morris KG; McMurtry IF; Oka M
J Appl Physiol (1985); 2006 Mar; 100(3):996-1002. PubMed ID: 16322374
[TBL] [Abstract][Full Text] [Related]
17. ROCK controls matrix synthesis in vascular smooth muscle cells: coupling vasoconstriction to vascular remodeling.
Chapados R; Abe K; Ihida-Stansbury K; McKean D; Gates AT; Kern M; Merklinger S; Elliott J; Plant A; Shimokawa H; Jones PL
Circ Res; 2006 Oct; 99(8):837-44. PubMed ID: 16990566
[TBL] [Abstract][Full Text] [Related]
18. Dexfenfluramine discontinuous treatment does not worsen hypoxia-induced pulmonary vascular remodeling but activates RhoA/ROCK pathway: consequences on pulmonary hypertension.
Desbuards N; Antier D; Rochefort GY; Apfeldorfer CS; Schenck E; Hanton G; Hyvelin JM
Eur J Pharmacol; 2009 Jan; 602(2-3):355-63. PubMed ID: 19049806
[TBL] [Abstract][Full Text] [Related]
19. Cilostazol suppresses angiotensin II-induced vasoconstriction via protein kinase A-mediated phosphorylation of the transient receptor potential canonical 6 channel.
Nishioka K; Nishida M; Ariyoshi M; Jian Z; Saiki S; Hirano M; Nakaya M; Sato Y; Kita S; Iwamoto T; Hirano K; Inoue R; Kurose H
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2278-86. PubMed ID: 21799177
[TBL] [Abstract][Full Text] [Related]
20. Dynamin-related protein 1-mediated mitochondrial mitotic fission permits hyperproliferation of vascular smooth muscle cells and offers a novel therapeutic target in pulmonary hypertension.
Marsboom G; Toth PT; Ryan JJ; Hong Z; Wu X; Fang YH; Thenappan T; Piao L; Zhang HJ; Pogoriler J; Chen Y; Morrow E; Weir EK; Rehman J; Archer SL
Circ Res; 2012 May; 110(11):1484-97. PubMed ID: 22511751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
